Government Pharmaceutical Organization

SK Hynix Inc., the global No. 2 memory chipmaker, is slated to invest more than 120 trillion won ($90.7 billion) by 2046 to build the world’s ...

The Dubai Chamber of Commerce in the United Arab Emirates (UAE) will open an office in Seoul, South Korea by May this year, according to industry so...

South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., announced on Sunday that it plans to develop a government-wide hyperscal...

Bond sales in South Korea amounted to 71.8 trillion won ($54.4 billion) in February, 12.4% up from a month prior, according to a report from the Kor...

South Korea’s antitrust body launched a probe into alleged violations of consumer protection regulations by China’s AliExpress, as Chine...

South Korea’s headline inflation rebounded in February from a six-month low on higher prices of oil and agricultural products, adding to expec...

The South Korean government on Monday tapped Mirae Asset Securities Co. as the brokerage chosen to sell treasury bonds, the sale of which will be la...

The South Korean financial regulator announced basic guidelines under the so-called corporate value-up program on Monday, with measures to boost the...

South Korea’s KT&G Corp., the world’s leading tobacco maker, appointed its Chief Operating Officer Bang Kyung-man as the final candi...

South Korea will nurture the small modular reactor (SMR) foundry business to revive the country’s nuclear power industry by rolling back the p...

South Korea's Lotte Chemical Corp. announced on Thursday that it has established artificial intelligence (AI) organizations tailored to the characte...

South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and developmen...

South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...

South Korea’s large business groups are in emergency mode to brace for proxy fights with activist funds at annual general meetings (AGMs) next...

Samsung Group affiliates’ unionized workers on Monday launched a joint organization to improve their bargaining power in terms of wages and we...

South Korea’s economics scholars oppose government-led countermeasures, including compensation packages, to handle mounting retail investor lo...

South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...

The South Korean government is seeking to lower the country’s video streaming service, or over-the-top (OTT) media service, rates as part of i...

The South Korean stock market has seen increased volatility and few rallies over the past three months, in sharp contrast to government hopes that i...

South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...

Kakao Corp. is set to replace executives of SM Entertainment Co., who ousted its founder Lee Soo-man when the South Korean mobile giant acquired the...

South Korean electric vehicle and battery makers including Hyundai Motor Group and LG Energy Solution Ltd. have asked the US to ease requirements fo...

South Korea’s LG Chem Ltd., the parent of the world’s second-largest electric vehicle battery maker LG Energy Solution Ltd., expects up ...

South Korea will scrap a plan to impose taxes on capital gains from financial products for all shareholders and further lower securities transaction...

South Korea’s top automaker Hyundai Motor Co. will invest 70 billion Indian rupees ($845 million) to expand and upgrade its Indian car manufac...

Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...

Police in Seoul have launched a probe into South Korea’s POSCO Holdings Inc. Chairman and Chief Executive Choi Jeong-woo and the company's boa...

South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

South Korea’s top financial regulator is detecting more circumstances of naked short-selling worth tens of millions of dollars by foreign inve...